Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model

Hearing loss is the main limitation of radiation therapy for vestibular schwannoma (VS), and identifying treatment options that minimize hearing loss are urgently needed. Treatment with bevacizumab is associated with tumor control and hearing improvement in neurofibromatosis type 2 (NF2) patients; h...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Proc Natl Acad Sci U S A
Hoofdauteurs: Gao, Xing, Zhao, Yingchao, Stemmer-Rachamimov, Anat O., Liu, Hao, Huang, Peigen, Chin, ShanMin, Selig, Martin K., Plotkin, Scott R., Jain, Rakesh K., Xu, Lei
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: National Academy of Sciences 2015
Onderwerpen:
Biological Sciences
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4664377/
https://ncbi.nlm.nih.gov/pubmed/26554010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1512570112
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items